Hemodynamic Response During Goal Directed Fluid Therapy in the OR
NCT ID: NCT02365688
Last Updated: 2017-07-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
18 participants
INTERVENTIONAL
2014-09-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraoperative Haemodynamic Optimization Comparing Flow and Pressure Parameters
NCT02104687
Goal-directed Intraoperative Fluid Therapy in High-risk Surgery
NCT02470221
Goal Directed Therapy for Patients Undergoing Major Vascular Surgery
NCT01681251
Goal-Directed Fluid Therapy for Patients Undergoing Oro-Maxillofacial Surgery
NCT03086694
Evaluation of Goal-Directed Intraoperative Hemodynamic Optimization Protocol
NCT02057653
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Initial bolus pre-incision
Initial pre-incision bolus of 500 cc of fluids with hemodynamic response recorded
Initial bolus pre-incision
Measured hemodynamic response to pre-incision bolus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Initial bolus pre-incision
Measured hemodynamic response to pre-incision bolus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. American Society of Anaesthesiologists (ASA) Physical Status 1 - 3
3. Expected duration of surgical procedure to be ≥ 2 hours
4. Standard of care monitoring to include cardiac output
Exclusion Criteria
2. Cardiac arrhythmia such as atrial fibrillation.
3. Right Ventricular Failure
4. Aortic regurgitation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic - MITG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy E Miller, MB ChB, FRCA
Role: PRINCIPAL_INVESTIGATOR
DUHS Department of Anestheiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVMOPR0436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.